Dana Investment Advisors, Inc. Seagen Inc. Transaction History

Dana Investment Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $24,752 - $39,397	194 Added 5.74%	3,572 $723,000
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $166,313 - $197,203	-1,417 Reduced 29.55%	3,378 $434,000
Q3 2022 Nov 15, 2022	BUY	$135.27 - $180.11 $425,424 - $566,445	3,145 Added 190.61%	4,795 $656,000
Q4 2021 Feb 09, 2022	SELL	$142.57 - $190.86 $4,847 - $6,489	-34 Reduced 2.02%	1,650 $255,000
Q2 2021 Aug 10, 2021	SELL	$135.08 - $161.1 $11,076 - $13,210	-82 Reduced 4.64%	1,684 $266,000
Q1 2021 May 13, 2021	BUY	$137.51 - $190.8 $242,842 - $336,952	1,766 New	1,766 $245,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.